BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Porta C, Paglino C. Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib. World J Hepatol 2010; 2(3): 103-113 [PMID: 21160981 DOI: 10.4254/wjh.v2.i3.103]
URL: https://www.wjgnet.com/1948-5182/full/v2/i3/103.htm
Number Citing Articles
1
Camillo Porta, Palma Giglione, Alessandra Ferrari, Francesca Reversi, Wanda Liguigli, Ilaria Imarisio, Carlo Ganini. Tivantinib (ARQ197) in hepatocellular carcinomaExpert Review of Anticancer Therapy 2015; 15(6): 615 doi: 10.1586/14737140.2015.1050383
2
Kanchan Vishnoi, Rong Ke, Karan S. Saini, Navin Viswakarma, Rakesh Sathish Nair, Subhasis Das, Zhengjia Chen, Ajay Rana, Basabi Rana. Berberine Represses β-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma CellsMolecular Pharmacology 2021; 99(1): 1 doi: 10.1124/molpharm.120.000029
3
P. Fitzmorris, M. Shoreibah, B. S. Anand, A. K. Singal. Management of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology 2015; 141(5): 861 doi: 10.1007/s00432-014-1806-0
4
Xuelian Zhao, Lynne W Elmore, Curtis C Harris, Xin Wei Wang. Encyclopedia of Life Sciences2011;  doi: 10.1002/9780470015902.a0006112.pub2
5
Xin Xie, Yiran Zhou, Xue Wang, Jian Guo, Jingwen Li, Hongye Fan, Jie Dou, Baiyong Shen, Changlin Zhou. Enhanced antitumor activity of gemcitabine by polysaccharide-induced NK cell activation and immune cytotoxicity reduction in vitro/vivoCarbohydrate Polymers 2017; 173: 360 doi: 10.1016/j.carbpol.2017.06.024
6
Carmen Berasain, María Ujue Latasa, Raquel Urtasun, Saioa Goñi, María Elizalde, Oihane Garcia-Irigoyen, María Azcona, Jesús Prieto, Matías A. Ávila. Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver CancerCancers 2011; 3(2): 2444 doi: 10.3390/cancers3022444
7
Rie Matsushima‐Nishiwaki, Seiji Adachi, Takashi Yoshioka, Eisuke Yasuda, Yasumasa Yamagishi, Junya Matsuura, Masato Muko, Rutsu Iwamura, Takahiro Noda, Hidenori Toyoda, Yuji Kaneoka, Yukio Okano, Takashi Kumada, Osamu Kozawa. Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen‐activated protein kinases and AKT pathwaysJournal of Cellular Biochemistry 2011; 112(11): 3430 doi: 10.1002/jcb.23270
8
Christopher L. Daige, Jason F. Wiggins, Leslie Priddy, Terri Nelligan-Davis, Jane Zhao, David Brown. Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver CancerMolecular Cancer Therapeutics 2014; 13(10): 2352 doi: 10.1158/1535-7163.MCT-14-0209
9
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizonOncotarget 2012; 3(3): 236 doi: 10.18632/oncotarget.466
10
Ronnie TP Poon, Nicholas Borys. Lyso-Thermosensitive Liposomal Doxorubicin: An Adjuvant to Increase The Cure Rate of Radiofrequency Ablation in Liver CancerFuture Oncology 2011; 7(8): 937 doi: 10.2217/fon.11.73
11
I Fasolino, V Guarino, M Marrese, V Cirillo, M Vallifuoco, M L Tamma, V Vassallo, A Bracco, F Calise, L Ambrosio. HepG2 and human healthy hepatocyte in vitro culture and co-culture in PCL electrospun platforms Biomedical Materials 2017; 13(1): 015017 doi: 10.1088/1748-605X/aa8c51